Constanze Jonak

About Constanze Jonak

Constanze Jonak, With an exceptional h-index of 22 and a recent h-index of 18 (since 2020), a distinguished researcher at Medizinische Universität Wien,

His recent articles reflect a diverse array of research interests and contributions to the field:

Cutaneous Oncology

Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients

Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)

Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)

Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit …

Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells

Mortalität, prognostische Parameter und Behandlungsstrategien bei Mycosis fungoides

Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides

Constanze Jonak Information

University

Position

___

Citations(all)

2022

Citations(since 2020)

1474

Cited By

1035

hIndex(all)

22

hIndex(since 2020)

18

i10Index(all)

37

i10Index(since 2020)

31

Email

University Profile Page

Google Scholar

Top articles of Constanze Jonak

Cutaneous Oncology

SEXUALLY TRANSMITTED INFECTIONS

2024/2/1

Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients

Journal of the European Academy of Dermatology and Venereology

2024/1/26

Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)

Scientific Reports

2024

Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)

British Journal of Dermatology

2024/4/10

Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit …

British Journal of Dermatology

2024/4/10

Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells

Nature Communications

2024/4/2

Mortalität, prognostische Parameter und Behandlungsstrategien bei Mycosis fungoides

JDDG: Journal der Deutschen Dermatologischen Gesellschaft

2024/4

Constanze Jonak
Constanze Jonak

H-Index: 12

Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides

JDDG: Journal der Deutschen Dermatologischen Gesellschaft

2024/4

Constanze Jonak
Constanze Jonak

H-Index: 12

Regulation of the immune cell repertoire in psoriasis patients upon blockade of IL-17a or TNFα

Dermatology and Therapy

2024/3/8

Constanze Jonak
Constanze Jonak

H-Index: 12

Lymphomatoid papulosis in paediatric population: results of a multicentre retrospective cohort study

European Journal of Cancer

2023/9/1

Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis

Journal of Allergy and Clinical Immunology

2023/8/1

Single‐cell RNA sequencing analysis of a COVID‐19–associated maculopapular rash in a patient with psoriasis treated with ustekinumab

The Journal of Dermatology

2023/8

303 Single-cell RNA sequencing of erythrodermic CTCL compared to atopic dermatitis and unspecific chronic erythroderma defines disease-specific markers

Journal of Investigative Dermatology

2023/5/1

455 Evolution of patient characteristics and treatment effectiveness in the real-world cohort of the Austrian psoriasis registry over a timespan of 18 years since the millenium

Journal of Investigative Dermatology

2023/5/1

150 Single-cell RNA sequencing defines disease-specific differences between prurigo nodularis and atopic dermatitis

Journal of Investigative Dermatology

2023/5/1

Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria–results the APPRECIATE study

Therapeutic Advances in Chronic Disease

2023/2

Constanze Jonak
Constanze Jonak

H-Index: 12

Cutaneous T cell lymphoma atlas reveals malignant Th2 cells supported by a B cell-rich microenvironment

bioRxiv

2023

Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika‐Therapie bei Patienten des Österreichischen Psoriasis‐Registers von 2004 bis 2022

JDDG: Journal der Deutschen Dermatologischen Gesellschaft

2023/12

Constanze Jonak
Constanze Jonak

H-Index: 12

Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004–2022

JDDG: Journal der Deutschen Dermatologischen Gesellschaft

2023/12

Constanze Jonak
Constanze Jonak

H-Index: 12

121 AB cell-rich tumor microenvironment delineates cutaneous T cell lymphoma from benign inflammatory skin diseases

Journal of Investigative Dermatology

2023/11/1

See List of Professors in Constanze Jonak University(Medizinische Universität Wien)